Alpha Tau Financials
| DRTS Stock | USD 2.80 0.06 2.10% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.55 | 12.0749 |
|
|
Investors should never underestimate Alpha Tau's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Alpha Tau's cash flow, debt, and profitability to make informed and accurate decisions about investing in Alpha Tau Medical.
Net Income |
|
Alpha | Select Account or Indicator |
Understanding current and past Alpha Tau Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alpha Tau's financial statements are interrelated, with each one affecting the others. For example, an increase in Alpha Tau's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Alpha Tau's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Alpha Tau Medical. Check Alpha Tau's Beneish M Score to see the likelihood of Alpha Tau's management manipulating its earnings.
Alpha Tau Stock Summary
Alpha Tau competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, Enliven Therapeutics, and Molecular Partners. Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of solid cancer In Israel and the United States. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel. Alpha Tau is traded on NASDAQ Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | IL0011839383 |
| CUSIP | 42228C101 M0740A108 |
| Location | Israel |
| Business Address | Kiryat Hamada Street |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.alphatau.com |
| Phone | 972 3 577 4115 |
| Currency | USD - US Dollar |
Alpha Tau Key Financial Ratios
| Return On Equity | -0.33 | ||||
| EBITDA | (28.03 M) | ||||
| Net Income | (29.16 M) | ||||
| Cash Per Share | 1.63 X | ||||
| Current Ratio | 41.98 X |
Alpha Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alpha Tau's current stock value. Our valuation model uses many indicators to compare Alpha Tau value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alpha Tau competition to find correlations between indicators driving Alpha Tau's intrinsic value. More Info.Alpha Tau Medical is rated # 2 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . At this time, Alpha Tau's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Alpha Tau by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Alpha Tau Medical Systematic Risk
Alpha Tau's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alpha Tau volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Alpha Tau Medical correlated with the market. If Beta is less than 0 Alpha Tau generally moves in the opposite direction as compared to the market. If Alpha Tau Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alpha Tau Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alpha Tau is generally in the same direction as the market. If Beta > 1 Alpha Tau moves generally in the same direction as, but more than the movement of the benchmark.
Alpha Tau Thematic Clasifications
Alpha Tau Medical is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Medical Equipment | View |
Today, most investors in Alpha Tau Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alpha Tau's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alpha Tau growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Alpha Tau November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Alpha Tau help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alpha Tau Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alpha Tau Medical based on widely used predictive technical indicators. In general, we focus on analyzing Alpha Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alpha Tau's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.49 | |||
| Information Ratio | 0.0705 | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (3.78) | |||
| Potential Upside | 7.14 |
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.